✦ LIBER ✦

Methylation profile of genes CDKN2A (p14 and p16), DAPK1, CDH1, and ADAM23 in head and neck cancer

✍ Scribed by Marilia F. Calmon; Jucimara Colombo; Fabrício Carvalho; Fátima P. Souza; José F.G. Filho; Érica E. Fukuyama; Anamaria A. Camargo; Otávia L.S. Caballero; Eloíza H. Tajara; José A. Cordeiro; Paula Rahal

Book ID: 113513043
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 227 KB
Volume: 173
Category: Article
ISSN: 0165-4608
DOI: 10.1016/j.cancergencyto.2006.09.008

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Promoter methylation of p16, DAPK, CDH1,

Promoter methylation of p16, DAPK, CDH1, and TIMP-3 genes in cervical cancer: correlation with clinicopathologic characteristics

✍ D.H. JEONG; M.Y. YOUM; Y.N. KIM; K.B. LEE; M.S. SUNG; H.K. YOON; K.T. KIM 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB

Methylation profile of CCNA1, P16, HIC1,

Methylation profile of CCNA1, P16, HIC1, TIMP3, MGMT and DCC genes in head and neck cancer

📂 Article 📅 2012 🏛 Elsevier 🌐 English ⚖ 53 KB

Gene methylation of SFRP2, P16, DAPK1, H

Gene methylation of SFRP2, P16, DAPK1, HIC1, and MGMT and KRAS mutations in sporadic colorectal cancer

✍ Sacide Pehlivan; Mehmet Artac; Tugce Sever; Hakan Bozcuk; Can Kilincarslan; Must 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 279 KB

Temporal inactivation of p16 (CDKN2, INK

Temporal inactivation of p16 (CDKN2, INK4A, MTS-1) tumor suppressor gene: Is p 16 the gatekeeper gene of head and neck squamous cell carcinoma?

✍ Andre L. Reed; Joseph A. Califano III; William H. Westra; David Sidransky; Wayne 📂 Article 📅 1997 🏛 SAGE Publications 🌐 English ⚖ 116 KB

Deletional, mutational, and methylation

Deletional, mutational, and methylation analyses of CDKN2 (p16/MTS1) in primary and metastatic prostate cancer

✍ David F. Jarrard; G. Steven Bova; Charles M. Ewing; Sokhom S. Pin; Son H. Nguyen 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB 👁 1 views

The tumor suppressor gene CDKN2 (p16/MTS1) resides on chromosome 9p21 and encodes a 16 kDa inhibitor of the cyclin-dependent kinases. Inactivation of CDKN2 by homozygous deletion, point mutation, and recently described aberrant methylation in the 5' promoter region may increase progression through t

Promoter methylation and loss of p16INK4

Promoter methylation and loss of p16INK4a gene expression in head and neck cancer

✍ Semra Demokan; Alice Chuang; Yusufhan Suoğlu; Murat Ulusan; Zubeyde Yalnız; Jose 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 350 KB